Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy

Brain

Volumn 134, Issue 6, 2011, Pages 1853-1863

  Ebenezer, Gigi J ^a   O'Donnell, Ryan ^a   Hauer, Peter ^a   Cimino, Nicholas P ^a   McArthur, Justin C ^a   Polydefkis, Michael ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 1550 Orleans Street CRB II ^*  (United States)

Author keywords

blood vessels; diabetic neuropathy; peripheral nerve regeneration; Schwann cells; stereology

Indexed keywords

CAPSAICIN; CD31 ANTIGEN; NEUROMODULIN; PROTEIN P75;

ADULT; ARTICLE; BLOOD VESSEL; BRAIN ATROPHY; CELL DENSITY; CELL MIGRATION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DENERVATION; DERMIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; EPIDERMIS; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE FIBER TRANSECTION; NERVE GROWTH; NERVE REGENERATION; NERVE SPROUTING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SCHWANN CELL; SKIN BIOPSY; STEREOLOGY;

ADULT; AUTONOMIC DENERVATION; AXONS; AXOTOMY; BIOPSY; BLOOD VESSELS; CAPSAICIN; DERMIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GAP-43 PROTEIN; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; NERVE REGENERATION; NEURAL CONDUCTION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PERIPHERAL NERVES; SCHWANN CELLS; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 79957843443     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr086     Document Type: Article

References (64)

1. Anton ES, Weskamp G, Reichardt LF, Matthew WD. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA 1994; 91: 2795-9. (Pubitemid 24139435)
2. Bates D, Taylor GI, Minichiello J, Farlie P, Cichowitz A, Watson N, et al. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol 2003; 255: 77-98. (Pubitemid 36287142)
3. Bentley CA, Lee KF. p75 is important for axon growth and schwann cell migration during development. J Neurosci 2000; 20: 7706-15.
4. Bisby MA. Axonal transport of labeled protein and regeneration rate in nerves of streptozocin-diabetic rats. Exp Neurol 1980; 69: 74-84. (Pubitemid 10085203)
5. Bondeva T, Ruster C, Franke S, Hammerschmid E, Klagsbrun M, Cohen CD, et al. Advanced glycation end-products suppress neuropilin-1 expression in podocytes. Kidney Int 2009; 75: 605-16.
6. Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG, et al. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006; 65: 26-36.
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20. (Pubitemid 34000785)
8. Capla JM, Grogan RH, Callaghan MJ, Galiano RD, Tepper OM, Ceradini DJ, et al. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 2007; 119: 59-70. (Pubitemid 46360247)
9. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature 2005; 436: 193-200. (Pubitemid 41021263)
10. Charonis AS, Tsilbary EC. Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 1992; 41 (Suppl 2): 49-51.
11. Duran-Jimenez B, Dobler D, Moffatt S, Rabbani N, Streuli CH, Thornalley PJ, et al. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 2009; 58: 2893-903.
12. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986; 19: 440-9. (Pubitemid 16116477)
13. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-24. (Pubitemid 23121981)
14. Ebenezer GJ, Laast VA, Dearman B, Hauer P, Tarwater PM, Adams RJ, et al. Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model. J Comp Neurol 2009; 514: 272-83.
15. Eichmann A, Le Noble F, Autiero M, Carmeliet P. Guidance of vascular and neural network formation. Curr Opin Neurobiol 2005; 15: 108-15. (Pubitemid 40249969)
16. Ekstrom AR, Tomlinson DR. Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. J Neurol Sci 1989; 93: 231-7. (Pubitemid 19280544)
17. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002; 108: 122-8. (Pubitemid 35373824)
18. Gora-Kupilas K, Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol 2005; 43: 31-9. (Pubitemid 40533190)
19. Griffin JW, Nguyen HA, TT. Neural repair and plasticity. In: Michael ES, Stephanie C, Leonardo C, Pamela D, Fred G, editors. Textbook of neural repair and rehabilitation. Cambridge University Press; 2006. p. 293-303.
20. Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH. Measuring nerve regeneration in the mouse. Exp Neurol 2010; 223: 60-71.
21. Gu C, Rodriguez ER, Reimert DV, Shu T, Fritzsch B, Richards LJ, et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 2003; 5: 45-57. (Pubitemid 36827341)
22. Hahn K, Sirdofsky M, Brown A, Ebenezer G, Hauer P, Miller C, et al. Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy. J Peripher Nerv Syst 2006; 11: 142-7. (Pubitemid 43894081)
23. Hobson MI, Green CJ, Terenghi G. VEGF enhances intraneural angio-genesis and improves nerve regeneration after axotomy. J Anat 2000; 197 (Pt 4): 591-605. (Pubitemid 32051540)
24. Hoke A, Gordon T, Zochodne DW, Sulaiman OA. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol 2002; 173: 77-85. (Pubitemid 34081727)
25. Jaap AJ, Shore AC, Stockman AJ, Tooke JE. Skin capillary density in subjects with impaired glucose tolerance and patients with type 2 diabetes. Diabet Med 1996; 13: 160-4. (Pubitemid 26075525)
26. Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D. Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats. Diabetes 1981; 30: 797-803. (Pubitemid 11020050)
27. Jakobsen J, Sidenius P. Decreased axonal flux of retrogradely transported glycoproteins in early experimental diabetes. J Neurochem 1979; 33: 1055-60. (Pubitemid 10188736)
28. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002; 99: 11946-50.
29. Katz MA, McCuskey P, Beggs JL, Johnson PC, Gaines JA. Relationships between microvascular function and capillary structure in diabetic and nondiabetic human skin. Diabetes 1989; 38: 1245-50. (Pubitemid 19247419)
30. Kennedy JM, Zochodne DW. Impaired peripheral nerve regeneration in diabetes mellitus. J Peripher Nerv Syst 2005; 10: 144-57. (Pubitemid 40984889)
31. Kennedy JM, Zochodne DW. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 2000; 123 (Pt 10): 2118-29.
32. Lehtinen JM, Uusitupa M, Siitonen O, Pyorala K. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989; 38: 1307-13. (Pubitemid 19247428)
33. Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 2001; 101: 367-74. (Pubitemid 32372426)
34. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55: 1513-20.
35. Peterson DA, Jones DG. Determination of neuronal number and process surface area in organotypic cultures: a stereological approach. J Neurosci Methods 1993; 46: 107-20. (Pubitemid 23061020)
36. Polydefkis M, Hauer P, Griffin JW, McArthur JC. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 2001; 3: 23-8. (Pubitemid 32405674)
37. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004; 127: 1606-15. (Pubitemid 38899413)
38. Quattrini C, Jeziorska M, Boulton AJ, Malik RA. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 2008; 31: 140-5.
39. Rajan B, Polydefkis M, Hauer P, Griffin JW, McArthur JC. Epidermal reinnervation after intracutaneous axotomy in man. J Comp Neurol 2003; 457: 24-36. (Pubitemid 36172570)
40. Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 1999; 154: 355-63. (Pubitemid 29094086)
41. Ropper AH, Gorson KC, Gooch CL, Weinberg DH, Pieczek A, Ware JH, et al. Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol 2009; 65: 386-93.
42. Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 2001; 107: 1083-92. (Pubitemid 32422905)
43. Schwarz Q, Gu C, Fujisawa H, Sabelko K, Gertsenstein M, Nagy A, et al. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev 2004; 18: 2822-34. (Pubitemid 39507774)
44. Sigaudo-Roussel D, Demiot C, Fromy B, Koitka A, Leftheriotis G, Abraham P, et al. Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice. Diabetes 2004; 53: 1564-9. (Pubitemid 38697670)
45. Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with impaired glucose tolerance: implications for diagnosis and therapy. Curr Treat Options Neurol 2005; 7: 33-42. (Pubitemid 40220517)
46. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res 1999; 846: 219-28. (Pubitemid 29505158)
47. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 2000; 12: 4243-54. (Pubitemid 32037835)
48. Song XY, Zhou FH, Zhong JH, Wu LL, Zhou XF. Knockout of p75(NTR) impairs re-myelination of injured sciatic nerve in mice. J Neurochem 2006; 96: 833-42.
49. Taniguchi M, Matsuzaki S, Tohyama M. P75 plays a key role in the induction of the sprouting of sensory nerve fibers in inflamed skin. J Invest Dermatol 2007; 127: 2062-5. (Pubitemid 47075364)
50. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-6. (Pubitemid 35396976)
51. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat 1999; 194 (Pt 1): 1-14. (Pubitemid 29126690)
52. Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993; 36: 1266-74. (Pubitemid 23353025)
53. Tesfaye S, Selvarajah D. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 2650-1. (Pubitemid 41007857)
54. Thornalley PJ. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 2002; 50: 37-57.
55. Tomlinson DR, Fernyhough P, Diemel LT. Neurotrophins and peripheral neuropathy. Philos Trans R Soc Lond B Biol Sci 1996; 351: 455-62. (Pubitemid 126745354)
56. Tomlinson DR, Fernyhough P, Diemel LT. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 1997; 46 (Suppl 2): S43-9.
57. Tosaki T, Kamiya H, Yasuda Y, Naruse K, Kato K, Kozakae M, et al. Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons. Exp Neurol 2008; 213: 381-7.
58. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482-97.
59. Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 1992; 166: 265-70.
60. Yasuda H, Dyck PJ. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987; 37: 20-8. (Pubitemid 17230103)
61. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M, et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003; 69: 229-85. (Pubitemid 36581874)
62. Yu CQ, Zhang M, Matis KI, Kim C, Rosenblatt MI. Vascular endothelial growth factor mediates corneal nerve repair. Invest Ophthalmol Vis Sci 2008; 49: 3870-8.
63. Zhu H, Li F, Yu WJ, Wang WJ, Li L, Wan LD, et al. Effect of hypoxia/ reoxygenation on cell viability and expression and secretion of neuro-trophic factors (NTFs) in primary cultured schwann cells. Anat Rec (Hoboken) 2010; 293: 865-70.
64. Ziegler D, Gries FA, Spuler M, Lessmann F. The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 1992; 6: 49-57. (Pubitemid 23034751)